摘要
本文介绍了FDA对苯丙醇胺 (PPA ,phenylpropanolamine)的研究历史、不良反应的最新研究情况和结论以及FDA采取的措施 。
The research history,epidemiological result of adverse reaction of phenylpropanolamine(PPA)and action taken by FDA on PPA were discussed in this paper.Based on this recent foreign situation,SDA(State Drug Administration)temporarily stopped using and marketing PPA in China. [
出处
《中国新药杂志》
CAS
CSCD
2000年第12期852-853,共2页
Chinese Journal of New Drugs